Adastra Holdings Dividends and Buybacks
Dividend criteria checks 0/6
Adastra Holdings does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Market Cool On Adastra Holdings Ltd.'s (CSE:XTRX) Revenues Pushing Shares 26% Lower
Oct 23
Market Cool On Adastra Holdings Ltd.'s (CSE:XTRX) Revenues Pushing Shares 26% Lower
Sep 08Is Adastra Holdings (CSE:XTRX) A Risky Investment?
Sep 04Adastra Holdings Ltd. (CSE:XTRX) Might Not Be As Mispriced As It Looks After Plunging 41%
Jul 11Adastra Holdings Ltd. (CSE:XTRX) Might Not Be As Mispriced As It Looks After Plunging 27%
May 08Adastra Holdings Ltd.'s (CSE:XTRX) Shares Leap 26% Yet They're Still Not Telling The Full Story
Mar 08Adastra Holdings Ltd.'s (CSE:XTRX) Shares Not Telling The Full Story
Jan 23Here's Why Adastra Holdings (CSE:XTRX) Can Afford Some Debt
Sep 28Subdued Growth No Barrier To Adastra Holdings Ltd.'s (CSE:XTRX) Price
Aug 03Does Adastra Holdings (CSE:XTRX) Have A Healthy Balance Sheet?
Jan 13We Think Adastra Holdings (CSE:XTRX) Has A Fair Chunk Of Debt
Sep 28Does Adastra Holdings (CSE:XTRX) Have A Healthy Balance Sheet?
Mar 23Here's Why Adastra Holdings (CSE:XTRX) Can Afford Some Debt
Dec 07Here's Why Phyto Extractions (CSE:XTRX) Can Afford Some Debt
Aug 18Auditors Have Doubts About Phyto Extractions (CSE:XTRX)
May 04Adastra Labs Holdings (CSE:XTRX) Is Making Moderate Use Of Debt
Dec 10Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if XTRX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if XTRX's dividend payments have been increasing.
Dividend Yield vs Market
| Adastra Holdings Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (XTRX) | n/a |
| Market Bottom 25% (CA) | 1.8% |
| Market Top 25% (CA) | 6.2% |
| Industry Average (Pharmaceuticals) | 2.4% |
| Analyst forecast (XTRX) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate XTRX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate XTRX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate XTRX's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as XTRX has not reported any payouts.